Wednesday, July 27, 2016

BRIEF-Karyopharm says Selinexor received orphan drug designation from FDA

* Says Selinexor has received orphan drug designation from

U.S. Food and Drug Administration for treatment of soft tissue

sarcoma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)